Related Experiment Video
Updated: Aug 7, 2026

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses
Published on: November 16, 2016
[Mechanism and clinical application of carcinogenesis control by IFN]
Teruhisa Yamamoto1, Shuhei Nishiguchi
1Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine.
Abstract:
In Japan, most of hepatocellular carcinoma (HCC) developed in the patients with hepatitis C virus (HCV) related chronic liver disease. In these patients, hepatic cells repeat necrosis and rebirth. As a result, it is considered that persistent inflammation accumulate DNA mutation and finaly develop HCC. In patients infected with HCV, IFN therapy prevents the development of HCC by eradication of HCV. Our findings demonstrated that cell prolificaion was suppressed in proportion to the dose of IFN in human liver cancer cell lines. It is important to establish the clinical marker to assess the carcinogenic potential in each patient. Because it is related to the analysis of carcinogenic control and/or the accurate evaluations of clinical effect by IFN in HCC.
More Related Videos
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
10:00High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
Related Concept Videos
Mutagenicity and Carcinogenicity
Inhibitors of Viral Protein Synthesis
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Intrinsic Apoptotic Pathway
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers